SUMMARY A single oral dose of ciprofloxacin 500 mg was used to treat five men with gonococcal urethritis and five men with gonococcal proctitis, and all were cured. In a subsequent study the dose of ciprofloxacin was reduced to 250 mg, and 54 men with 57 gonococcal infections (47 urethral, seven rectal, and three pharyngeal) were treated; of the isolates of Neisseria gonorrhoeae, four were penicillinase producing strains. All the patients were cured of gonococcal infection.
Introduction
Strains of Neisseria gonorrhoeae showing either decreased sensitivity to penicillin (minimum inhibitory concentrations (MICs) 0 12-2,ug/1) or P lactamase mediated resistance to penicillin are now causing serious concern.'-3 Spectinomycin has been regarded as the best alternative to penicillin for treating acute gonococcal infections,4 but spectinomycin resistant strains of N gonorrhoeae have recently begun to emerge.56 The newer (3 lactamase stable cephalosporins, such as cefotaxime and ceftriaxone, are effective,7 8 but they cannot be given orally. There is therefore interest in non-P lactam antimicrobials that are active against N gonorrhoeae and can be administered orally.
Recent development of the 4-quinolone group of antibiotics has resulted in a series of compounds that are active against N gonorrhoeae and can be given orally. Some of these, such as acrosoxacin9 10 15 January 1985 the activity of 11 4-quinolone antibiotics against N gonorrhoeae in vitro, and noted that a new member of the group, ciprofloxacin, was the most active.'2 Furthermore, Ridgway et al have shown that ciprofloxacim is active against Chlamydia trachomatis;13 this might be of clinical importance in view of the common association of this organism with N gonorrhoeae. 14 We report here the results of a dose ranging study ofthe effectiveness of single oral dose of ciprofloxacin against uncomplicated gonococcal infections of the male urethra, rectum, and pharynx, and against concomitant infection with C trachomatis.
Patients and methods
All the patients were studied in the department of genitourinary medicine at this hospital between November 1983 and February 1984. Men who had taken antibiotics during the preceding month were excluded, but otherwise patients were unselected. All gave informed consent to participating in the study.
After local and general examination had been performed, specimens were collected as follows. Urethral specimens were taken with a plastic loop; one was spread on to a slide for Gram staining, and another inoculated on to culture medium for the isolation of 302
Single dose ciprofloxacin for treating gonococcal infections in men N gonorrhoeae. Next, an endourethral wire swab tipped with cotton wool was inserted 4-5 cm into the urethra and transferred to 2 ml culture medium for C trachomatis. Rectal and pharyngeal specimens were collected only from homosexual men. Rectal wall sampling was performed through a proctoscope, and wooden swabs tipped with cotton wool were used to collect material for Gram staining and for culture for Ngonorrhoeae and C trachomatis. Material from the tonsillar beds and posterior pharyngeal wall was also collected with cotton wool tipped wooden swabs for culture for N gonorrhoeae. We examined first catch urine specimens from all patients for albumin and sugar and took blood samples for routine haematology and biochemistry tests and serological tests for syphilis.
We made a presumptive diagnosis of gonococcal urethritis or proctitis if intracellular Gram negative diplococci were seen in urethral or rectal smears, and these patients were treated immediately; the diagnosis of gonorrhoea was confirmed by culture in every case. In some patients with gonococcal proctitis, and all with pharyngitis, diagnosis depended on the results of culture; treatment was started when these were available. Treatment was with a single oral dose of ciprofloxacin, 500 mg in the first part of the study and 250 mg in the second. The drug was administered with a glass of water under supervision. Patients were asked to return for re-examination on days 3, 7, and 14 after treatment. At each attendance they were asked about symptoms and examined clinically, then urethral or rectal smears were taken for Gram staining and microscopy, specimens were taken from previously infected sites for culture for N gonorrhoeae, and first catch urine specimens were examined. Cell culture for C trachomatis was performed during the second and third examinations after treatment. Blood sampling for haematology and biochemistry tests was repeated on day 3. Post gonococcal urethritis (PGU) was diagnosed if 10 or more polymorphonuclear leucocytes (PMNL) per high power field (x 100 objective) were present in a Gram stained urethral smear, or if 15 or more PMNL per medium power field (x 40 objective) were present in urinary sediment 10 or more days after treatment. LABORATORY 
METHODS
Culture for N gonorrhoeae was performed on a modified Thayer-Martin medium,'5 and isolates were identified by immunofluorescence and sugar fermentation. Cell culture for C trachomatis was performed using cycloheximide treated McCoy cells. '6 Results TREATMENT WITH 500 mg CIPROFLOXACIN We treated 10 men who had confirmed gonococcal infections with a single oral dose of ciprofloxacin 500 mg. Five of the men had urethral infections (one with a penicillinase producing strain of N gonorrhoeae (PPNG), and five had rectal infections. N gonorrhoeae was not isolated again from any of the men during follow up. One of the men with urethral gonococcal infections had a concomitant infection with C trachomatis, and this organism was isolated again at the first examination after treatment. None of the men with rectal infections yielded chlamydiae before or after treatment.
TREATMENT WITH 250 mg CIPROFLOXACIN We treated 54 men who had confirmed gonococcal infections with a single oral dose of ciprofloxacin 250 mg. These men had a total of 57 infections with N gonorrhoeae; 47 urethral, seven rectal, and three pharyngeal. Of the 47 urethral infections, four were with PPNG strains and one with a non-PPNG strain that also showed reduced sensitivity to penicillin (MIC 2 Mg/l). N gonorrhoeae was not isolated again from any of the 47 men with gonococcal urethritis. None of the seven rectal infections were with PPNG strains; N gonorrhoeae was not isolated again from any patient. Similarly, the three pharyngeal infections were with non-PPNG strains, and N gonorrhoeae was not isolated again from any patient.
EFFECT OF CIPROFLOXACIN ON CONCURRENT INFECTION WITH C TRACHOMATIS
Urethral specimens from nine (19/o) of the 47 men with gonococcal urethritis yielded C trachomatis before treatment and seven days after treatment. In a further seven men, who were chlamydia negative before treatment, the organisms were isolated 7-14 days after treatment (table I) . 
Discussion
The uniform cure of men with uncomplicated gonococcal infections that we obtained with single oral dose of ciprofloxacin is encouraging, and at least in our clinic population there seems to be no need for a dose higher than the 250 mg that we used. In the study reported here, ciprofloxacin was equally effective against urethral and rectal infections. The cure of three pharyngeal infections is interesting, because these are often difficult to eradicate."'
In this dosage ciprofloxacin was ineffective against C trachomatis. In this respect it resembles other antimicrobial agents with good in vitro antichlamydial activity, such as thiamphenicol, minocycline, and rifampicin with erythromycin, none of which are effective against genital chlamydiae in single dosage. [18] [19] [20] No doubt this poor antichlamydial activity was largely the reason for PGU occurring in 45% of patients, a figure not very different from the incidences found in men treated with other antimicrobials in single dosage.'8 20 21 Ciprofloxacin was well tolerated subjectively, but liver function test results became abnormal after treatment in 11I% of patients. The signs of hepatotoxicity were not pronounced, but they were there; this aspect will need close study in future clinical trials.
Our results show that ciprofloxacin may be a useful alternative to existing single dose treatment of gonorrhoea. The drug has the advantage of being a single oral regimen with freedom from major side effects. We suggest that it is studied further in both men and women. The effectiveness of a dose lower than the 250 mg that we used should also be studied.
